Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol
复制标题
DOI：
10.1227/neuprac.0000000000000062
复制
发表时间：
2023-12-01
期刊：
影响因子：
--
通讯作者：
Quinones-Hinojosa，Alfredo
中科院分区：
文献类型：
--
作者：
Ramos-Fresnedo，Andres;Al-Kharboosh，Rawan;Quinones-Hinojosa，Alfredo
